|
Volumn 6, Issue 4, 2015, Pages 606-612
|
Design, synthesis and biological evaluation of imidazopyridine/imidazopyrimidine-benzimidazole conjugates as potential anticancer agents
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CASPASE 3;
IMIDAZOPYRIDINE IMIDAZOPYRIMIDINE BENZIMIDAZOLE CONJUGATE DERIVATIVE;
NOCODAZOLE;
TUBULIN;
UNCLASSIFIED DRUG;
A549 CELL LINE;
ANIMAL CELL;
ANTIPROLIFERATIVE ACTIVITY;
APOPTOSIS;
ARTICLE;
BINDING SITE;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DNA FRAGMENTATION ASSAY;
DRUG CYTOTOXICITY;
DRUG DESIGN;
DRUG PROTEIN BINDING;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
DU 145 CELL LINE;
ENZYME ACTIVATION;
FEMALE;
FLOW CYTOMETRY;
G2 PHASE CELL CYCLE CHECKPOINT;
HELA CELL LINE;
HUMAN;
HUMAN CELL;
HYDROGEN BOND;
IC50;
IMMUNOFLUORESCENCE TEST;
IMMUNOHISTOCHEMISTRY;
IN VITRO STUDY;
MALE;
MELANOMA B16;
MOLECULAR DOCKING;
MOLECULAR MODEL;
NONHUMAN;
PRIORITY JOURNAL;
PROSTATE CANCER CELL LINE;
STRUCTURE ACTIVITY RELATION;
TUBULIN POLYMERIZATION ASSAY;
|
EID: 84928003990
PISSN: 20402503
EISSN: 20402511
Source Type: Journal
DOI: 10.1039/c4md00400k Document Type: Article |
Times cited : (57)
|
References (32)
|